Regulation of T-cell chemotaxis by programmed Death-Ligand 1 (PD-L1) in dry eye-associated corneal inflammation

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 7, 2010, Pages 3418-3423

  El Annan, Jaafar ^a   Goyal, Sunali ^a   Zhang, Qiang ^a   Freeman, Gordon J ^a   Sharpe, Arlene H ^a   Dana, Reza ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; FLUORESCEIN; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN ANTIBODY; SCOPOLAMINE; B7 ANTIGEN; BLOCKING ANTIBODY; CD3 ANTIGEN; CHEMOKINE; MEMBRANE PROTEIN; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CORNEA EPITHELIUM; DOWN REGULATION; DRY EYE; EPIFLUORESCENCE MICROSCOPY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KERATITIS; LYMPHOCYTE HOMING; LYMPHOCYTIC INFILTRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PIGMENT DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; STAINING; T LYMPHOCYTE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL MOTION; DISEASE MODEL; FLUOROPHOTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD3; ANTIGENS, CD80; CELL MOVEMENT; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; DRY EYE SYNDROMES; EPITHELIUM, CORNEAL; FEMALE; FLUOROPHOTOMETRY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KERATITIS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 77955905634     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3684     Document Type: Article

References (45)

1. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;36: 318-326.
2. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19:201-211.
3. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 200;42:2283-2292.
4. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cyto-kines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45:4293-4301.
5. Pflugfelder SC, Farley W, Luo L et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol. 2005;166:61-71.
6. Gulati A, Sacchetti M, Bonini S, Dana R. Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch Ophthalmol. 2006;124:710-716.
7. Hemady R, Chu W, Foster CS. Keratoconjunctivitis sicca and cor-neal ulcers. Cornea. 1990;9:170-173.
8. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173-1180.
9. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopu-lations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci. 2002;43:2609-2614.
10. De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by inter-feron-gamma. Invest Ophthalmol Vis Sci. 2007;48:2553-2560.
11. Niederkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress induces T cell-mediated Sjögren's syndrome-like lacrimal kerato-conjunctivitis. J Immunol. 2006;176:3950-3957.
12. Pflugfelder SC, de Paiva CS, Li DQ, Stern ME. Epithelial-immune cell interaction in dry eye. Cornea. 2008;27(suppl 1):S9-S11.
13. Ecoiffier T, El-Annan J, Rashid S, Schaumberg D, Dana R. Modulation of integrin alpha-4 beta-1 (VLA-4) in dry eye disease. Arch Ophthalmol. 2008;126:1695-1699.
14. Chauhan SK, El-Annan J, Ecoiffier T, et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol. 2009;182:1247-1252.
15. El-Annan J, Chauhan SK, Ecoiffier T, Zhang Q, Saban DR, Dana R. Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci. 2009;50:3802-3807.
16. Latchman YE, Liang SC, Wu Y, et al. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci U S A. 2004;101: 10691-10696.
17. Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR. The function of donor compared with recipient programmed death-ligand 1 in corneal allograft survival. J Immunol. 2007;179:3672-3679.
18. Ansari MJ, Salama AD, Chitnis T, et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 2003;198:63-69.
19. Keir ME, Liang SC, Guleria I, et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med. 2006;203:883-895.
20. Yang W, Li H, Chen PW, et al. PD-L1 expression on human ocular cells and its possible role in regulating immune-mediated ocular inflammation. Invest Ophthalmol Vis Sci. 2009;50:273-280.
21. Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci. 2005;46:2766-2771.
22. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008;126:219-225.
23. Eppihimer MJ, Gunn J, Freeman GJ, et al. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation. 2002;9:133-145.
24. Rodig N, Ryan T, Allen JA, et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol. 2003;33:3117-126.
25. Lemp MA. Report of the National Eye Institute/industry workshop on clinical trials in dry eyes. CLAOJ. 1995;21:221-232.
26. Jin Y, Shen L, Chong EM, et al. The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis. 2007; 13:626-634.
27. Mott KR, Osorio Y, Brown DJ, et al. The corneas of naive mice contain both CD4 and CD8+ T cells. Mol Vis. 2007;13:1802-1812.
28. Herz U, Bunikowski R, Mielke M, Renz H. Contribution of bacterial superantigens to atopic dermatitis. Int Arch Allergy Immunol. 1999;118:240-241.
29. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol. 2001;2:123-128.
30. Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000; 192:1027-1034.
31. Mazanet MM, Hughes CC. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol. 2002;169:3581-3588.
32. Cao Y, Zhou H, Tao J, et al. Keratinocytes induce local tolerance to skin graft by activating interleukin-10-secreting T cells in the context of costimulation molecule B7-H1. Transplantation. 2003;75: 1390-1396.
33. Ritchie MH, Fillmore RA, Lausch RN, Oakes JE. A role for NF-kB binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004;45:2299-2305.
34. Hong JW, Liu JJ, Lee JS, et al. Proinflammatory chemokine induction in keratocytes and inflammatory cell infiltration into the cornea. Invest Ophthalmol Vis Sci. 2001;42:2795-2803.
35. Yamagami H, Yamagami S, Inoki T, Amano S, Miyata K. The effects of proinflammatory cytokines on cytokine-chemokine gene expression profiles in the human corneal endothelium. Invest Ophthalmol Vis Sci. 2003;44:514-520.
36. Wuest T, Farber J, Luster A, Carr DJ. CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell Immunol. 2006;243:83-89.
37. Hamrah P, Zhang Q, Liu Y, Dana MR. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci. 2002;43:639-646.
38. Hamrah P, Liu Y, Qiang Z, Dana MR. Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol. 2003;121:1132-1140.
39. Mataki N, Kikuchi K, Kawai T, et al. Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases. Am J Gastroenterol. 2007;102:302-312.
40. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677-704.
41. Dudler J, Li J, Pagnotta M, et al. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival. Transplantation. 2006;82:1733-1737.
42. Jeon DH, Oh K, Oh BC, et al. Porcine PD-L1: cloning, characterization, and implications during xenotransplantation. Xenotransplantation. 2007;14:236-242.
43. Su YH, Yan XT, Oakes JE, Lausch RN. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection.J Virol. 1996;70:1277-1281.
44. Tumpey TM, Cheng H, Yan XT, Oakes JE, Lausch RN. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10.JLeukoc Biol. 1998;63:486-492.
45. Qian Y, Dekaris I, Yamagami S, Dana MR. Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants. Arch Ophthalmol. 2000;118:1666-1671.